Opportunity ID: 138013

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-AI-12-019
Funding Opportunity Title:: Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards:: 1
Assistance Listings Number(s):: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Jan 13, 2012
Last Updated Date::
Original Closing Date for Applications:: Jun 01, 2012
Current Closing Date for Applications:: Jun 01, 2012
Archive Date:: Jul 02, 2012
Estimated Total Program Funding:: $ 10,000,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Public housing authorities/Indian housing authorities
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: The purpose of this FOA is to encourage submission of applications for the Leadership Group for a Clinical Research Network on Antibacterial Resistance. The Leadership Group (LG) will have overall responsibility for designing, prioritizing, implementing and managing the networks clinical research agenda to address antibacterial resistance (AR) scientific priorities. Applications for the LG must include an overview component and three functional components: a Leadership and Operations Center (LOC), a Laboratory Center (LC) and a Statistics and Data Management Center (SDMC).
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Package No: 1

Related Documents